We describe the cloning, expression and purification of the bovine XM866409 form of pyroglutamyl peptidase type-1 (PAP1). The cloned nucleotide sequence has an ORF coding for a primary sequence of 209 amino acid residues, which displays 98% identity with the human AJ278828 form of the enzyme. Three amino acid residues at positions 81, 205 and 208 were found to vary between the two sequences. The recombinant bovine PAP1 with a C-terminal His 6 tag (rBtaPAP1 6H ) was expressed in Escherichia coli XL10-Gold cells and purified by immobilised nickel ion affinity chromatography resulting in a yield of 2.6 mg of PAP1 per litre of culture. Purified rBtaPAP1 6H had a specific activity of 3633 units mg )1 . SDS-PAGE revealed a band for bovine PAP1 with a molecular weight of $24 kDa, which is in good agreement with previously reported data on PAP1. The K m and k cat values obtained for rBtaPAP1 6H were 59 lM and 3.5 s )1 , respectively. The optimum pH for activity was 9.0-9.5 and the optimum temperature was 37°C. rBtaPAP1 6H was found to have an absolute requirement for the thiol-reducing agent DTT, consistent with the expected property of a cysteine protease. Kinetic studies using the peptides pGlu-His-Pro-NH 2 (TRH), pGlu-Ala and pGlu-Val revealed K i values of 44.1, 141 and 652.17 lM, respectively. The lowest K i , observed for Thyrotropin-releasing Hormone (TRH), indicates that rBtaPAP1 6H has a higher affinity for tripeptides over dipeptides.
Introduction
Pyroglutamyl peptidase type-1 (PAP1; EC 3.4.19.3) is an omega peptidase that has the ability to remove pyroglutamic acid (pGlu) from the amino-terminus of biologically active peptides and proteins, with an apparent specificity for L-pGlu-L-amino acid optical isomers. In the MEROPS database PAP1 has been assigned as family C15, clan CF. As yet, no other peptidases have been assigned to this family or clan [1] .
The PAP1 activity has been reported to be widely present in several bacteria, plants, and animal tissues [2] [3] [4] [5] [6] . Typically, eukaryotic forms of PAP1 are monomeric cysteine peptidases with a relatively low molecular mass (approximately 23 kDa), a soluble or cytosolic location, and a pH optimum between 6.5 and 8.0 (see Cummins and O'Connor for review [7] ). Barrett and Rawlings [1] suggest that the cysteine peptidases have come from at least 7 different evolutionary origins, each of which has produced a sub-group with distinctive structures and properties, but almost all depend on catalytic diads of cysteine and histidine for activity.
PAP1 has been shown to have the ability to degrade/ inactivate a broad spectrum of pGlu-containing peptides including Thyrotropin-releasing Hormone (TRH), Luteinising Hormone-Releasing Hormone (LH-RH), Bombesin, Neurotensin, Anorexogenic peptide and Gastrins.
While the mammalian PAP1 enzymes have been implicated in the regulation of neuropeptide activity (e.g. the TRH pathway [8] and the neurotensin system [9] ) the exact nature of the physiological role of PAP1 still remains unclear. Within the human brain the highest PAP1 activity was found in the cortices and the lowest in the cerebellum [8] . Falkous et al. [9] have observed significantly increased levels of PAP1 in the spinal cord of patients suffering from motor neuron disease and found that PAP1 from human cerebral cortex is extremely susceptible to inhibition by potentially neurotoxic metal ions. Faivre-Bauman et al. [10] demonstrated that addition of specific inhibitors of PAP1 and Prolyl Endopeptidase (EC 3.4.21.26) to TRH-synthesising hypothalamic cells in primary culture results in a significant increase in both their TRH content and in the amount of TRH being released from these cells.
Recent studies carried out with the aid of a chemically synthesised TRH analogue (which is resistant to PAP degradation) indicated a 'neuromodulating' role for PAP1 in the control of the formation of cyclo(His-Pro) from TRH [11] .
Yoshimoto et al. [12] have cloned the gene for the Bacillus amyloliquefaciens PAP1 enzyme and, following expression in E. coli, have shown that the recombinant enzyme appears to exist as a dimer, suggesting differences between the recombinant and wild type forms of the enzyme. Other studies indicate that the recombinant PAP1 from Bacillus subtilis and Streptococcus pyogenes are probably tetramers, whilst the recombinant PAP1 from Pseudomonas fluorescens appears to be dimeric in nature [7] .
The 3-dimensional structures of four prokaryotic PAP1 enzymes have been solved using X-ray crystallography, which include B. amyloliquefaciens, Thermococcus litoralis, Pyrococcus horikoshii and Pyrococcus furiosus [13] [14] [15] [16] .
In a recent study the human PAP1 was cloned and expressed using an insect cell expression system. The sequence enabled the construction of a cartoon model of the human enzyme, based on known PAP1 structures including those for B. amyloliquefaciens and T. litoralis. Biochemical data showed that human PAP1 has an optimum pH of 9.0-9.5, an optimum temperature of 50°C and a K m value of 50 lM [17] .
Here we report the cloning, expression and purification of catalytically active rBtaPAP1 6H in E. coli XL10-Gold. The enzyme was biochemically characterised and a number of kinetic parameters were determined. These findings correlate with data reported for various other mammalian PAP1 enzymes.
Materials and methods

Strains, plasmids and enzymes
Escherichia coli XL10-Gold (Tet R , D(lvqA) 183 D (mcrCB-hsdSMR-mrr)173, endA1, supE44, thi-1, recA1, gyrA96, relA1, lac Hte[F' proAB lacI q ZDM15 Tn10(tet R ) Amy Cam R ]) (Stratagene) was employed for both cloning and protein expression. The plasmid vector pCR2.1 (Invitrogen) was used for the cloning and amplification of bovine PAP1 cDNA and the plasmids pQE-60 (Qiagen) and pPC225 (a modified derivative of the pKK223-3 expression vector from Amersham Pharmacia with an insertion of 1800 bp in the MCS BamHI site, for ease of cloning [18] ), were used to construct expression vectors for rBtaPAP1 6H . MMLV reverse transcriptase was purchased from Sigma. Restriction enzymes, REDTaq DNA polymerase and T4 ligase were purchased from Invitrogen and were used according to supplier's recommendations.
Chemicals, materials and reagents
Bovine brain tissue samples were obtained from Kepak, Clonee, Co. Meath, Ireland. Oligonucleotides were purchased from MWG Biotech AG. E. coli was routinely grown on Luria-Bertani (LB) media, which was obtained from the Scharlau Microbiology. Peptides (pGlu-His-Pro-NH 2 , pGlu-Ala-OH and pGlu-Val-OH) and fluorogenic substrate pGlu-AMC were purchased from Bachem.
Ni-NTA resin, used for purification, was purchased from Qiagen. All other chemicals, including buffers and antibiotics, were purchased from Sigma-Aldrich.
RNA isolation
Bovine brain tissue (100 mg) was homogenised in 1 ml of Trizol reagent using a glass-Teflon homogeniser and transferred to a microfuge tube. The sample was incubated at room temperature for 5 min to allow complete dissociation of nucleoprotein complexes. Then 200 ll of chloroform was added, mixed by brief vortexing and incubated at room temperature for 3 min. The phases were separated and the upper aqueous layer was transferred to a fresh microfuge tube. An equal volume of isopropanol was added and mixed by inversion. The sample was incubated at room temperature to precipitate the RNA. The supernatant was removed and the RNA pellet was washed with 1 ml of 70% ethanol. The RNA pellet was air-dried, dissolved in 30 ll RNasefree water and stored at )80°C.
Reverse transcription
The sequence for the putative bovine PAP1 gene was obtained from the GenBank nucleotide sequence database at NCBI (http://www.ncbi.nlm.nih.gov), accession number XM866409.
One microgram of bovine RNA was combined with 1 ll of 25 lM specific reverse primer P R 5¢-CAGCAAGG ATCCGTGTTCATGGCAACAGTTG-3¢ and the volume made to 5 ll with dH 2 O. The mixture was incubated at 70°C for 10 min and then placed on ice for 5 min. Reverse transcription was initiated by adding specific 10· enzyme buffer, 500 lM of each dNTP and 1 unit MMLV reverse transcriptase. The volume was brought to 20 ll with dH 2 O. The first strand was synthesised at 37°C for 60 min followed by inactivation of the MMLV reverse transcriptase at 95°C for 2 min. The cDNA was used as template for polymerase chain reaction (PCR).
PCR and cloning of the bovine PAP1 gene
The PCR was performed using a PTC-200 Peltier Thermal Cycler. The PCR volume was 50 ll containing 1 ll template (10-100 ng), 1.0-2.5 mM MgCl 2 , 0.5 lM of each primer, 200 lM of each dNTP, 1 unit REDTaq polymerase and 5 ll specific 10· enzyme buffer. The parameters for amplification were as follows: denaturation of 95°C for 10 min for one cycle, followed by 30 cycles of 95°C for 1 min, 64.5°C for 30 s and 72°C for 1 min. A final extension at 72°C for 10 min was also included.
The region encoding the PAP1 gene was amplified using primers P F 5¢-GAACCCGCCATGGAGCAGCCCAGGAA-GGCGG-3¢ and P R 5¢-CAGCAAGGATCCGTGTTCATG-GCAACAGTTG-3¢. The primers were designed to include unique restriction sites NcoI and BamHI (underlined) to facilitate the subsequent cloning of the PCR product into pQE60.
The bovine PAP1 gene was cloned into the TA cloning vector pCR2.1 and then subcloned, using the NcoI and BamHI sites, into the pQE60 vector generating pZK2. Utilising the pZK2 vector encoded EcoRI and HindIII sites, the bovine PAP1 gene was subcloned into the expression vector pPC225 [18] generating the pZK3 expression plasmid, having the ORF for recombinant Bos taurus PAP1 in fusion with a His 6 tag on the C-terminal (rBtaPAP1 6H ) ( Fig. 1 ). The sequence of pZK3 was verified by DNA sequencing (MWG Biotech AG).
Expression of recombinant bovine PAP1
A 1 l volume of LB broth containing ampicillin (100 lg ml )1 ), tetracycline (10 lg ml )1 ) and chloramphenicol (25 lg ml )1 ) was inoculated with 10 ml of a stationary phase culture of E. coli XL10-Gold harbouring pZK3. Cultures were grown at 37°C at 220 rpm until an OD 600 of 0.35 was reached. IPTG was added to a final concentration of 
Purification of His 6 -tagged PAP1
A total, 3 ml of Ni-NTA resin was gently mixed with 30 ml of crude lysate for 60 min at 4°C. The mixture was poured into a 0.7 · 15 cm column, allowing the resin to settle as the liquid passed through. The column was washed four times with 15 ml buffer A containing 20 mM imidazole and eluted with 3 · 5 ml fractions buffer A containing 200 mM imidazole. The elute was dialysed overnight against 1 l buffer A and stored at 4°C. Protein purity and yield were analysed by SDS-PAGE. Protein concentration was determined by standard BCA assay.
Standard fluorimetric activity assay PAP1 activity was determined according to the method by Fujiwara and Tsuru [19] , as modified by Browne and O'Cuinn [20] . The quantitative assay was performed in triplicate using 96-well microtitre plates. Briefly, 25 ll PAP1 sample was incubated at 37°C for 15 min with 100 ll pGlu-AMC substrate (final concentration 250 lM) in buffer A containing, at final concentration: Dithiothreitol (DTT) (10 mM), EDTA (2 mM) and 5% (v/v) DMSO. The reaction was terminated by the addition of 100 ll 1.5 M acetic acid. Negative controls were also included in each assay by adding acetic acid to the enzyme prior to the substrate. Liberated AMC was detected using a Perkin Elmer LS-50B plate reader spectrophotometer with excitation and emission wavelengths of 370 and 440 nm, respectively. The fluorescence readings were converted to nanomoles of AMC released per minute using a standard curve of AMC prepared under identical assay conditions.
Determination of protein concentration
All samples were dialysed extensively against ultrapure water prior to assaying in order to remove interfering substances. Protein concentration was determined by the enhanced bicinchoninic acid (BCA) assay described by Smith et al. [21] . Sample (50 ll) was incubated with 200 ll BCA reagent at 37°C for 30 min, after which the absorbance at 570 nm was determined. BSA was used as a standard for this assay.
SDS-PAGE, Western blotting and zymography
Samples were separated by SDS-PAGE using duplicate 4-12% acrylamide/bis-acrylamide gels (10·12 cm). One was stained using 0.25% (w/v) Coomassie blue solution and the other was transferred to a nitrocellulose membrane for Western blotting. After transfer the membrane was incubated with blocking buffer for 1 h, followed by incubation for 1 h with anti-His 6 AEHRP conjugate antibody, at ambient temperature. Peroxidase signals were detected using SuperSignal West Pico Chemiluminescent substrate (Pierce). The luminescent image was overlayed with an image of the molecular markers on the blot. For zymogram analysis, samples were electrophoresed at 4°C on 15% acrylamide/bis-acrylamide gels. The gels were subsequently incubated for 15 min at 37°C with buffer A containing 5 lM pGlu-AMC and 10 mM DTT. The gel was visualised under UV light.
Effect of pH and temperature
A pH range 6.0-10.5 was used to observe the effect of pH on rBtaPAP1 6H activity. The standard assay was carried out using the following buffers: 50 mM potassium phosphate, pH 6.0-8.0; 50 mM Tris-HCl, pH 7.5-9.5 and 50 mM NaOH/glycine, pH 9.5-10.5. rBtaPAP1 6H samples were preincubated at 37°C for 10 min prior to addition of the substrate solution.
Purified enzyme was assayed in triplicate for 15 min, as previously described, at seven different temperatures: 4, 22, 30, 37, 40, 50 and 60°C.
Kinetic studies
The Michaelis constant (K m ) was determined using a range of concentrations of pGlu-AMC (10-500 lM), prepared in buffer A containing at final concentration 10 mM DTT, 2 mM EDTA and 5% (v/v) DMSO. Purified rBtaPAP1 6H was assayed for PAP1 activity in triplicate with each substrate concentration. K m , V max (maximal velocity) and k cat (turnover number) values of rBtaPAP1 6H for the substrate pGlu-AMC were obtained by fitting the data to Lineweaver and Burk [22] , Eadie-Hofstee [23] and HanesWoolf [24] kinetic models. These parameters were also determined using Enzfitter software from Biosoft, Cambridge, UK. Dissociation constant (K i ) was determined for three peptides pGlu-His-Pro-NH 2 (TRH), pGlu-Ala-OH and pGlu-Val-OH using a range of concentrations of pGlu-AMC (10-300 lM), prepared in buffer A containing at final concentration 10 mM DTT , 2 mM EDTA and 5% (v/v) DMSO. K i values were determined using the Lineweaver and Burk method [22] .
Statistical analysis
All assays were repeated three times and each reading was recorded in triplicate. Data was collated for statistical analysis and graphical representation shown here. All values are presented as mean together with 95% confidence limits. Differences between the parameters were taken as significant if p < 0.05. All analyses were calculated using SPSS statistical software application version 12.01.
Results
Cloning of bovine PAP1
The recombinant ORF of the B. taurus PAP1 with a His 6 sequence on the 3¢ end, cloned into the plasmid pZK3 ( Fig. 1) , is 680 bp in length. It differs from the human PAP1 sequence by 71 nucleotide residues. Most of these variations are silent substitutions and the corresponding 209 amino acid primary sequence has 98% identity with the human PAP1 sequence [17] , with only three amino acid residues being different (Fig. 2) .
Expression and purification of recombinant bovine PAP1
The rBtaPAP1 6H protein was purified from cleared lysate of a recombinant E. coli culture harbouring the plasmid pZK3 using Ni-NTA resin. Samples taken at various stages during the purification were analysed by SDS-PAGE. A prominent purified band was obtained, running with the 24 kDa protein marker (Fig. 3A) . The molecular weight of rBtaPAP1 6H is 24,016, as deduced from its amino acid sequence. A total of 2.6 mg purified rBtaPAP1 6H was obtained from one litre of E. coli culture. Zymogram analysis of this purified protein using the substrate pGlu-AMC (Fig. 3B) shows a correlation of PAP1 activity with the protein band. The presence of the His 6 tag was confirmed by Western blotting with antiHis 6 antibody (Fig. 3C) . Total yield and specific activity are given in Table 1 .
Biochemical characterisation of recombinant bovine PAP1
Prominent PAP1 activity was detected between pH 7.5 and 10.0, with activity dropping off sharply outside this pH range. rBtaPAP1 6H exhibited its optimum activity within the peak range of 9.0-9.5. Over the range of temperatures at which rBtaPAP1 6H was assayed, activity gradually increased and exhibited an optimum temperature of 37°C, then rapidly declined as the temperature reached 60°C. rBtaPAP1 6H activity was heavily dependent on thiolreducing reagent DTT. A rapid increase in activity was observed from 2 to 6 mM and above this concentration a plateau effect was observed.
Initial kinetics studies
The kinetic parameters of purified rBtaPAP1 6H were determined (Table 2A) . A K m value of 59 lM was determined using pGlu-AMC substrate at various concentrations ranging between 10 and 500 lM. V max and k cat values obtained for rBtaPAP1 6H were 3.15 units ml )1 and 3.5 s )1 , respectively.
K i values for a number of pGlu peptides were measured (Table 2B) . TRH had the lowest K i (44 lM), indicating the relative highest affinity and behaved as a competitive Fig. 2 . Alignment of the recombinant bovine PAP1 XM866409 (bovine) amino acid sequence with human PAP1 AJ278828 (homosapien). The three amino acid variations at positions 81, 205 and 208 are highlighted. The sequences were annotated using the Genedoc programme [25] . inhibitor (Fig. 4) . K i values for pGlu-Ala and pGlu-Val were 141 and 652 lM, respectively.
Discussion
In this study, the foremost aim was to clone the gene for bovine PAP1 and achieve high yield expression of the recombinant protein inclusive of a purification tag, which would facilitate purification. It was noted that in a previous study [17] , recombinant human PAP1, which had been expressed in a eukaryotic (insect) expression system, suffered the loss of the fused His 6 tag, possibly due to cleavage within the host cells. Seeing that similar cleavage may occur with the present bovine PAP1 in such a system, a prokaryotic expression host was considered prior to the utilisation of an insect or yeast cell expression system. Furthermore, higher yields would be possible in a prokaryotic system. E. coli is one of the most commonly used hosts of recombinant heterologous protein expression [26] . Studies to date on the native mammalian PAP1 enzymes indicate that the active forms are not glycosylated. A close sequence identity as well as very similar biochemical and catalytic properties between eukaryotic and prokaryotic PAP1 enzymes has been reported [7] . Active recombinant forms of several prokaryotic PAP1 enzymes have been successfully expressed in E. coli [12, [27] [28] [29] [30] , which has no reported endogenous PAP1 activity. Thus, it was decided to investigate expression of recombinant bovine PAP1 in E. coli, which, as shown here, was successful in yielding catalytically active enzyme.
The gene for bovine PAP1 was cloned into an E. coli expression plasmid (pZK3, Fig. 1 ). In this construct a His 6 ORF was inserted on the 3¢ end of the 680 bp bovine ORF so that the recombinant B. taurus protein would be expressed with a C-terminal His 6 tag (rBtaPAP1 6H ). In comparison to the human PAP1 nucleotide sequence [17] , there are 71 base differences. However, since most of these substitutions are silent, this results in only three amino acid changes along the length of the 209 residue primary sequence and the two proteins have 98% sequence identity (Fig. 2) . The residues Ala81, Cys205 and Glu208 correspond to Thr81, Tyr205 and Lys208 in the human sequence, respectively. The putative catalytic residues consisting of Glu85, Cys149 and His168 are fully conserved. Such a triad is a common feature of cysteine peptidases. The nucleophilic thiol group of cysteine requires a proton donor in the form of the imidazolium ring of histidine. Sometimes, as is possibly the case here, the imidazolium ring is orientated into the proximity of the thiol group by a third residue such as glutamic acid [1] .
Catalytically active rBtaPAP1 6H was expressed in cultures of E. coli harbouring pZK3, with specific PAP1 activity verified by zymogram analysis (Fig. 3B) . The presence of (Fig. 3C ). This C-terminal tag facilitated the use of nickel ion affinity purification, yielding up to 2.6 mg of highly pure rBtaPAP1 6H per litre of culture (Fig. 3A) .
The specific PAP1 activity of purified rBtaPAP1 6H was measured as 3633 units mg )1 (Table 1 ). This activity was optimal at pH 9.0-9.5, which compares well with data in the literature. Cummins and O'Connor [31] found the optimal pH for native bovine PAP1 purified from brain tissue to be 8.5 and Dando et al. [17] obtained maximal activity in the range of pH 7.0-9.0 for recombinant human PAP1. Awade et al. [32] found bacterial PAP1 to display an optimum pH of 7.0-9.0.
The optimal temperature for recombinant human PAP1 activity was reported to be 50°C [17] . However, rBtaPAP1 6H displayed 50% reduced activity at 50 and 60°C. Cummins and O'Connor reported that incubating the purified native bovine enzyme at 37°C for 45 min had no apparent effect on PAP1 stability. However, when incubated at 40 and 50°C for the same period PAP1 activity deceased by 17 and 65%, respectively [31] .
As with all cysteine peptidases [7] , rBtaPAP1 6H activity displayed an absolute requirement for a thiol-reducing agent. Increasing the DTT concentration to 8 mM resulted in a direct increase in activity, but above this amount no further rise was observed. The thiol of cysteine is a very reactive functional group. In vivo, this group can form complexes with various metal ions and is readily oxidised, forming cysteine disulphide bonds. Thiol-reducing Fig. 4 . K i determination for TRH using Lineweaver-Burk plot. Enzyme activity was measured under standard assay conditions using a range of pGlu-AMC concentrations (10-300 lM) (D -without inhibitor, h -with TRH). A total of 95% confidence limits were derived from fitted data in SPSS version 12.01 (n = 7, p < 0.001). A. Kinetic parameters of purified bovine PAP1 using methods listed. B. Activity of bovine PAP1 towards pyroglutamyl peptides. A total of 95% confidence limits were derived from fitted data in SPSS version 12.01. Enzyme assays were carried out as described in Materials and methods. The assays were repeated in triplicate (n = 7: p < 0.001). For the Lineweaver-Burk and Hanes-Woolf plots, K m is derived from the x-axis intercept of the fitted regression line.
agents such as DTT are required to prevent this from occurring. The Michaelis constant (K m ) of 59 lM determined for rBtaPAP1 6H compares well with the value of 50 lM reported for unpurified recombinant human PAP1 [17] . Unpublished data from this research group recorded K m values of 52 and 55 lM for purified and unpurified recombinant human PAP1, respectively which is in good agreement with the data by Dando et al. [17] . It is interesting to note that Cummins and O'Connor [31] obtained a K m value of 16 lM for native bovine PAP1.
Cummins and O'Connor [31] determined a dissociation constant (K i ) of 24.90 lM for TRH, 101 lM for pGlu-Ala and 820 lM for pGlu-Val for purified native bovine PAP1. The very similar results in this study (Table 2 ) confirm what earlier investigators have suggested, i.e. that PAP1 activity has a higher affinity for the hydrolysis of tripeptide substrates over dipeptide substrates.
Ultimately, the His 6 tag did not prevent the exhibition of characteristic mammalian PAP1 enzymatic activity, as shown by specific cleavage of pGlu from pGlu-AMC and sensitivity to the thiol-reducing agent DTT. We cannot eliminate completely the possibility that the His 6 tag exerts some degree of an effect on the catalytic properties of the enzyme. However, the protein displays the typical biochemical characteristics of PAP1-like enzymes. As described above, the primary sequence of bovine PAP1 differs from that of human PAP1 by only three residues (Fig. 2) . Kinetic and biochemical parameters reported for recombinant human PAP1 having no His 6 tag [17] correlate very closely to those presented here for recombinant His 6 -tagged bovine PAP1. Furthermore, the value for K m obtained here (59 lM) fits well into the range of K m values (15-150 lM) and various biochemical parameters reported for diverse mammalian native PAP1 enzymes [17, 20, 31, [33] [34] [35] [36] .
In conclusion, this study shows that rBtaPAP1 6H displays comparable biochemical and kinetic properties to native bovine, human and bacterial forms of the enzyme. This work has resulted in preparation of significant quantities of the highly purified enzyme, which could facilitate crystallisation studies. By combining X-ray crystallography and site-directed mutagenesis a structure/function relationship could be investigated. Crystallography allows researchers, through the study of protein crystals, to determine the threedimensional molecular structures of proteins. Such structure data is indispensable for correctly determining the often complex biological functions of macromolecules. An improved understanding of molecular structures and interactions of proteins allows the rational design of molecules that can inhibit or modulate protein activity, thus providing possible treatment for disease states in which PAP1 has been implicated.
